Business news – Page 80
-
Business
PPG to buy Mexican paints firm Comex
$2.3bn deal expands US firm’s footprint in Central America
-
Business
Bayer to close polycarbonate plant and cut 90 jobs
Firm has already shut Chinese plant, and will also sell off businesses in Australia and New Zealand
-
Business
Inhaled insulin approved in US
European committee recommends approval for generic long-acting insulin
-
Business
Affymax folds after drug withdrawal
Unexplained allergic reactions to anaemia drug prompt firm to dissolve
-
BusinessLithium-ion battery makers look to stimulate electric car production
Tesla Motors opens up patents and manufacturers plan capacity increases
-
Business
Biotech bounced back in 2013, says report
R&D investment increasing, but industry needs to use its cash more wisely
-
Business
Shire fends off AbbVie takeover bid
Board says deal undervalues the company and its growth potential
-
Business
Medtronic to buy Covidien for $43bn
Tax inversion deal continues consolidation theme among medical device makers
-
Business
Novo Nordisk to create 6000 jobs by 2022
Half of the new Danish employees will be in R&D roles
-
BusinessPharma vies to unleash immune system power on cancer
Immuno-oncological drugs look set to earn billions and significantly lengthen patients’ lives
-
Business
Merck & Co bolsters hepatitis C pipeline with Idenix acquisition
Early-stage drugs complement Merck’s own developmental portfolio
-
Business
Drug giants settle mismarketing lawsuits
Pfizer and GSK settle claims over promoting drugs for unapproved uses in the US
-
Business
Data sharing helps firms reduce Reach animal testing
Alternative in vitro methods slowly gaining traction for some tests
-
Business
Generics giants jostle over pain drug
Mylan and Actavis contest Teva’s generic celecoxib exclusivity
-
Business
Drug companies rapped for anticompetitive behaviour
Italian authorities demand €1.2 billion in damages from Roche, Novartis and Pfizer
-
FeatureTriple-stranded success story
Tom Brown is our Entrepreneur of the Year. He tells Sarah Houlton the secrets of his success
-
Business
Nano risk register not necessary, says BASF
Reach covers the relevant information, and a register risks attracting unwarranted stigma
-
OpinionMessy megamergers
Big company buyouts are more about immediate gains and rarely consider the impact on research, says Derek Lowe
-
BusinessChinese-made DNA sequencer aims to challenge foreign dominance
Domestic instrument pitching for a slice of the world’s fastest growing genome sequencing market